Radiation-induced sarcomas (RIS) are rare but severe long-term complications of radiotherapy (RT). They typically arise years after exposure to ionizing radiation used to treat primary malignancies and complicate patient outcomes. Determining the risk associated with these radiation-induced cancers is challenging due to confounding factors such as lifestyle and genetic predisposition. Liposarcomas, which are the most common type of soft tissue sarcomas, originate from adipose tissue and can develop as a late complication of RT. Although they account for a significant portion of soft tissue sarcomas, radiation-induced liposarcomas are still considered rare, making them a noteworthy diagnostic and therapeutic concern. In this report, we present a rare case of radiation-induced dedifferentiated liposarcoma arising 12 years after RT for vulvar cancer. The patient presented with a mass in the groin, which was initially suspected to be a local recurrence. Imaging studies revealed a suspicious lesion on PET/CT, while MRI showed no significant findings. Histopathological evaluation confirmed the diagnosis of dedifferentiated liposarcoma. Surgical resection was performed with a focus on achieving negative margins. A literature review identified nine similar cases, with five being pleomorphic liposarcomas. The average time to presentation was 15 years (interval 3 - 47 years), with a mean radiation dose of 62 Gy. This case highlights the importance of long-term follow-up for cancer survivors and the need for vigilance in diagnosing secondary malignancies following RT.
References
[1]
Arlen, M., Higinbotham, N.L., Huvos, A.G., Marcove, R.C., Miller, T. and Shah, I.C. (1971) Radiation-Induced Sarcoma of Bone. Cancer, 28, 1087-1099. https://doi.org/10.1002/1097-0142(1971)28:5<1087::aid-cncr2820280502>3.0.co;2-f
[2]
Cahan, W.G., Woodard, H.Q., Higinbotham, N.L., Stewart, F.W. and Coley, B.L. (1948) Sarcoma in Irradiated Bone. Report of Eleven Cases. Cancer, 1, 3-29. https://doi.org/10.1002/1097-0142(194805)1:1<3::aid-cncr2820010103>3.0.co;2-7
[3]
Murray, E.M., Werner, D., Greeff, E.A. and Taylor, D.A. (1999) Postradiation Sarcomas: 20 Cases and a Literature Review. InternationalJournalofRadiationOncologyBiologyPhysics, 45, 951-961. https://doi.org/10.1016/s0360-3016(99)00279-5
[4]
Carlos-Reyes, A., Muñiz-Lino, M.A., Romero-Garcia, S., López-Camarillo, C. and Hernández-de la Cruz, O.N. (2021) Biological Adaptations of Tumor Cells to Radiation Therapy. FrontiersinOncology, 11, Article ID: 718636. https://doi.org/10.3389/fonc.2021.718636
[5]
Hur, W. and Yoon, S. (2017) Molecular Pathogenesis of Radiation-Induced Cell Toxicity in Stem Cells. InternationalJournalofMolecularSciences, 18, Article No. 2749. https://doi.org/10.3390/ijms18122749
[6]
Snow, A., Ring, A., Struycken, L., Mack, W., Koç, M. and Lang, J.E. (2021) Incidence of Radiation Induced Sarcoma Attributable to Radiotherapy in Adults: A Retrospective Cohort Study in the SEER Cancer Registries across 17 Primary Tumor Sites. CancerEpidemiology, 70, Article ID: 101857. https://doi.org/10.1016/j.canep.2020.101857
[7]
Yap, J., Chuba, P.J., Thomas, R., Aref, A., Lucas, D., Severson, R.K., et al. (2002) Sarcoma as a Second Malignancy after Treatment for Breast Cancer. InternationalJournalofRadiationOncologyBiologyPhysics, 52, 1231-1237. https://doi.org/10.1016/s0360-3016(01)02799-7
[8]
Callesen, L.B., Safwat, A., Rose, H.K., Sørensen, F.B., Baad-Hansen, T. and Aggerholm-Pedersen, N. (2021) Radiation-Induced Sarcoma: A Retrospective Population-Based Study over 34 Years in a Single Institution. ClinicalOncology, 33, e232-e238. https://doi.org/10.1016/j.clon.2020.12.009
[9]
Mirjolet, C., Diallo, I., Bertaut, A., Veres, C., Sargos, P., Helfre, S., et al. (2022) Treatment Related Factors Associated with the Risk of Breast Radio-Induced-Sarcoma. RadiotherapyandOncology, 171, 14-21. https://doi.org/10.1016/j.radonc.2022.04.004
[10]
Mazonakis, M., Lyraraki, E. and Damilakis, J. (2021) Lifetime Radiation-Induced Sarcoma Risk in Patients Subjected to IMRT or VMAT for Uterine Cervix Carcinoma. PhysicalandEngineeringSciencesinMedicine, 44, 573-579. https://doi.org/10.1007/s13246-021-01002-5
[11]
Chen, Y., Ao, D., Zuo, C. and Cai, J. (2023) Biomarkers Associated with Radiation-Induced Lung Injury in Cancer Patients. JournalofBiosciencesandMedicines, 11, 209-224. https://doi.org/10.4236/jbm.2023.1110020
[12]
Sheth, G.R., Cranmer, L.D., Smith, B.D., Grasso-LeBeau, L. and Lang, J.E. (2012) Radiation-Induced Sarcoma of the Breast: A Systematic Review. TheOncologist, 17, 405-418. https://doi.org/10.1634/theoncologist.2011-0282
[13]
Zhang, A.Y., Judson, I., Benson, C., Wunder, J.S., Ray-Coquard, I., Grimer, R.J., et al. (2018) Correction: Chemotherapy with Radiotherapy Influences Time-to-Development of Radiation-Induced Sarcomas: A Multicenter Study. BritishJournalofCancer, 117, 326-331. https://doi.org/10.1038/s41416-018-0079-9
[14]
Lee, A.T.J., Thway, K., Huang, P.H. and Jones, R.L. (2018) Clinical and Molecular Spectrum of Liposarcoma. JournalofClinicalOncology, 36, 151-159. https://doi.org/10.1200/jco.2017.74.9598
[15]
Thway, K. (2019) Well-Differentiated Liposarcoma and Dedifferentiated Liposarcoma: An Updated Review. SeminarsinDiagnosticPathology, 36, 112-121. https://doi.org/10.1053/j.semdp.2019.02.006
[16]
Arbabi, L. and Warhol, M.J. (1982) Pleomorphic Liposarcoma Following Radiotherapy for Breast Carcinoma. Cancer, 49, 878-880. https://doi.org/10.1002/1097-0142(19820301)49:5<878::aid-cncr2820490510>3.0.co;2-r
[17]
Griem, K.L., Robb, P.K., Caldarelli, D.D. and Templeton, A.C. (1989) Radiation-Induced Sarcoma of the Thyroid. ArchivesofOtolaryngology—HeadandNeckSurgery, 115, 991-993. https://doi.org/10.1001/archotol.1989.01860320101028
[18]
Coatesworth, A.P., Martin-Hirsch, D.P. and MacDonald, A. (1996) Post-Irradiation Liposarcoma of the Temporal Bone. TheJournalofLaryngology&Otology, 110, 779-781. https://doi.org/10.1017/s0022215100134942
[19]
O’Malley, S., Weitman, D., Olding, M. and Sekhar, L. (1997) Multiple Neoplasms Following Craniospinal Irradiation for Medulloblastoma in a Patient with Nevoid Basal Cell Carcinoma Syndrome. JournalofNeurosurgery, 86, 286-288. https://doi.org/10.3171/jns.1997.86.2.0286
[20]
Orosz, Z., Rohonyi, B., Luksander, A. and Szántó, J. (2000) Pleomorphic Liposarcoma of a Young Woman Following Radiotherapy for Epithelioid Sarcoma. Pathology&OncologyResearch, 6, 287-291. https://doi.org/10.1007/bf03187333
[21]
Demir, D., Katircioglu, S., Suoglu, Y. and Bilgic, B. (2006) Radiation‐Induced Liposarcoma of the Retropharyngeal Space. Otolaryngology—HeadandNeckSurgery, 134, 1060-1062. https://doi.org/10.1016/j.otohns.2005.03.043
[22]
Yozu, M., Symmans, P., Dray, M., Griffin, J., Han, C., Ng, D., et al. (2013) Muir-Torre Syndrome-Associated Pleomorphic Liposarcoma Arising in a Previous Radiation Field. VirchowsArchiv, 462, 355-360. https://doi.org/10.1007/s00428-012-1369-x
[23]
Ninomiya, H., Miyoshi, T., Shirakusa, T., Shiraishi, T., Yamamoto, N. and Nabeshima, K. (2006) Postradiation Sarcoma of the Chest Wall: Report of Two Cases. SurgeryToday, 36, 1101-1104. https://doi.org/10.1007/s00595-004-3300-9
[24]
Watanabe, K., Tokiya, R., Kawata, Y., Matsuno, T., Tanaka, R., Taira, N., et al. (2024) Radiation-Induced Pleomorphic Liposarcoma after Hypofractionated Radiotherapy Following Breastconserving Surgery: A Case Report and Literature Review. OncologyLetters, 28, Article No. 325. https://doi.org/10.3892/ol.2024.14457
[25]
Hong, D., Yang, J., Sun, C., Liu, Y., Shen, L., Xu, B., et al. (2023) Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade. ClinicalCancerResearch, 29, 2869-2884. https://doi.org/10.1158/1078-0432.ccr-22-3567